# Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute

> **NCT05607186** · — · COMPLETED · sponsor: **Singapore General Hospital** · enrollment: 59 (actual)

## Conditions studied

- Rectal Cancer
- Oncology

## Interventions

- **RADIATION:** neoadjuvant long course chemoradiotherapy

## Key facts

- **NCT ID:** NCT05607186
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-01
- **Primary completion:** 2016-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2022-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05607186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05607186, "Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05607186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*